Werewolf Flow 50 During ACL Reconstruction
NCT: NCT04998656 · COMPLETED
Brief Summary
The aim of this study is to compare the outcomes, ease of use, and cost of the Werewolf FLOW50 device to the institutional standard of care which is does not include the use of electrocautery devices during anterior cruciate ligament reconstruction (ACLR) surgery in patients 12-18 years of age using a randomized control trial design. The investigators hypothesize that a lower proportion of participants who undergo ACLR and are randomized to the Werewolf FLOW50 procedure will experience post-operative arthrofibrosis compared to those randomized to standard of care (control group).
Frequently Asked Questions
What is Werewolf Flow 50 During ACL Reconstruction?
Werewolf Flow 50 During ACL Reconstruction is a clinical trial registered under NCT04998656. Current status: COMPLETED.
What is the status of NCT04998656?
The current status of NCT04998656 (Werewolf Flow 50 During ACL Reconstruction) is: COMPLETED.
When did Werewolf Flow 50 During ACL Reconstruction start?
Werewolf Flow 50 During ACL Reconstruction started on 2021-07-12.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.